We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

DIESSE DIAGNOSTICA SENESE SPA

DIESSE Diagnostica Senese S.P.A. manufactures in-vitro diagnostics systems for the hematology, seroimmunology and bac... read more Featured Products: More products

Download Mobile App





DIESSE Diagnostica Demonstrates Advanced Immunoassay and ESR Analyzers at EUROMEDLAB 2022

By LabMedica International staff writers
Posted on 12 Apr 2022

Diesse Diagnostica Senese S. More...

p.A. (Rigoni, Italy) demonstrated its CHORUS TRIO and VES MATIC 5 instruments at EUROMEDLAB 2022 which was held 10th-14th April 2022 in Munich, Germany.

CHORUS TRIO is an easy-to-use single test multiparametric system for immunometric assay. The single test device contains all the reagents necessary to perform the assay, thus eliminating hidden costs or waste of reagents. Ease of use and the most expansive selection of tests available on the market (infectious diseases, autoimmunity, endocrinology, and tumor markers, allergy, bone metabolism, inflammation) make it the ideal tool for performing small series diagnostic tests while ensuring maximum flexibility in organizing the clinical laboratory’s workflow. From the smallest to the largest, CHORUS TRIO easily adapts to the needs of any clinical analysis laboratory.

At EUROMEDLAB 2022, Diesse Diagnostica also demonstrated its new VES MATIC 5 automatic instrument for the determination of the ESR directly on the hematocrit tube (190 samples/hour), using racks from the main cell counters. ESR is a valuable laboratory test in a range of clinical conditions, such as rheumatoid diseases, orthopedic infections and Hodgkin’s lymphoma, and it can be used for the follow‐up of infectious, inflammatory, malignant and autoimmune diseases. Featuring IoT with internal cameras for advanced remote assistance, along with a modern and interactive graphic user interface, VES MATIC 5 offers continuous and random access loading of any kind of cell counter racks. Diesse Diagnostica plans to soon enable VES MATIC 5 to provide artificial intelligence-based recognition of lipemic, hemolyzed, coagulated and mislabeled samples.

Related Links:
Diesse Diagnostica Senese Spa 


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
Electrolyte Analyzer
BKE-B
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.